Loading...

Valerie Gruber, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-206-3943
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Kent State UniversityPh.D.1990Clinical Psychology
    UC BerkeleyM.P.H.1992School of Public Health
    Collapse Awards and Honors
    UCSF Clinical Psychology Training Program2014David Rea Training Award

    Collapse Overview 
    Collapse Overview
    VALERIE A. GRUBER is Professor in the Department of Psychiatry at UCSF, and faculty in the Public Service and Minorities Track of the UCSF Clinical Psychology Training Program. Dr. Gruber is a licensed psychologist, and holds an APA certificate in the treatment of alcohol and other substance use disorders. She completed a Ph.D. in Clinical Psychology at Kent State University, internship at the UCSF Clinical Psychology Training Program, and an M.P.H. at the University of California Berkeley. Her clinical, supervision, leadership, teaching and research efforts focus on developing clinical interventions for substance use disorders and associated medical conditions that are effective for low-income, culturally diverse substance users. Areas of expertise include trauma-informed integrated treatment of substance use health conditions in behavioral health and primary care settings. Skills include motivational interviewing, individual, couples and group psychotherapy, psychological assessment, cultural competence, staff development, program management and clinical research.


    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Guydish J, Tajima B, Le T, Henderson C, Yip D, Gruber V, Garcia W, Delucchi KL. Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control. 2016 Dec 02. PMID: 27913790.
      View in: PubMed
    2. Guydish J, Gruber V, Le T, Tajima B, Andrews KB, Leo H, Zura SK, Miller R, Tsoh JY. A Pilot Study of a Readiness Group to Increase Initiation of Smoking Cessation Services among Women in Residential Addiction Treatment. J Subst Abuse Treat. 2016 Apr; 63:39-45. PMID: 26825975.
      View in: PubMed
    3. Kyle TL, Horigian VE, Tross S, Gruber V, Pereyra M, Mandler RN, Feaster DJ, Metsch LR. Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS Behav. 2015 Mar; 19(3):536-42. PMID: 25074737; PMCID: PMC4312252 [Available on 03/01/16].
    4. Carrico AW, Flentje A, Gruber V, Woods WJ, Discepola MV, Dilworth SE, Neilands TB, Jain J, Siever MD. Community-based harm reduction substance abuse treatment with methamphetamine-using men who have sex with men. J Urban Health. 2014 Jun; 91(3):555-67. PMID: 24744105; PMCID: PMC4074324.
    5. McCance-Katz EF, Gruber V, Beatty G, Lum P, Ma Q, DiFrancesco R, Hochreiter J, Wallace PK, Faiman MD, Morse GD. Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism. Am J Addict. 2014 Mar-Apr; 23(2):137-44. PMID: 24118434; PMCID: PMC3984379.
    6. Gruber V, Rainey PM, Lum PJ, Beatty GW, Aweeka FT, McCance-Katz EF. Interactions between alcohol and the HIV entry inhibitor Maraviroc. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6):375-7. PMID: 23881910; PMCID: PMC4100473.
    7. McCance-Katz EF, Gruber V, Beatty G, Lum PJ, Rainey PM. Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. J Addict Med. 2013 Jul-Aug; 7(4):264-70. PMID: 23666322; PMCID: PMC3737351.
    8. Sorensen JL, Haug NA, Larios S, Gruber V, Tulsky J, Powelson E, Logan DP, Shapiro B. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012 Dec; 43(4):418-23. PMID: 23007110; PMCID: PMC3484182.
    9. McCance-Katz EF, Lum PJ, Beatty G, Gruber V, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr. 2012 Jul 1; 60(3):282-8. PMID: 22495786; PMCID: PMC3723399.
    10. Gruber V, Rainey PM, Moody DE, Morse GD, Ma Q, Prathikanti S, Pade PA, Alvanzo AA, McCance-Katz EF. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. Clin Infect Dis. 2012 Feb 1; 54(3):414-23. PMID: 22100576; PMCID: PMC3258270.
    11. Gruber V, McCance-Katz EF. Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Curr HIV/AIDS Rep. 2010 Aug; 7(3):152-60. PMID: 20532839; PMCID: PMC2892618.
    12. Gruber V, Delucchi KL, Kielstein A, Batki SL. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008 Apr 1; 94(1-3):199-206. PMID: 18243585; PMCID: PMC2821580.
    13. Haug NA, Shopshire M, Tajima B, Gruber V, Guydish J. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ. 2008; 38(2):181-92. PMID: 18724657; PMCID: PMC2742313.
    14. Haug NA, Sorensen JL, Gruber V, Lollo N, Roth G. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006 Nov; 30(6):752-81. PMID: 17050764.
      View in: PubMed
    15. Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007 Apr 17; 88(1):54-63. PMID: 17056206; PMCID: PMC1976289.
    16. Haug NA, Sorensen JL, Lollo ND, Gruber V, Delucchi KL, Hall SM. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005 Nov; 17(8):1022-9. PMID: 16176898.
      View in: PubMed
    17. Batki SL, Gruber V, Bradley JM, Bradley M, Delucchi K. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002 May 1; 66(3):283-93. PMID: 12062463.
      View in: PubMed
    18. Moos RH, Pettit B, Gruber V. Longer episodes of community residential care reduce substance abuse patients' readmission rates. J Stud Alcohol. 1995 Jul; 56(4):433-43. PMID: 7674679.
      View in: PubMed
    19. Moos RH, Pettit B, Gruber V. Characteristics and outcomes of three models of community residential care for abuse patients. J Subst Abuse. 1995; 7(1):99-116. PMID: 7655315.
      View in: PubMed
    20. Allen S, Serufilira A, Gruber V, Kegeles S, Van de Perre P, Carael M, Coates TJ. Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health. 1993 May; 83(5):705-10. PMID: 8484453; PMCID: PMC1694707.
    Valerie's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP